152
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Amniotic fluid clusterin in pregnancies complicated by the preterm prelabor rupture of membranes

, , , , , , , , & show all
Pages 2529-2537 | Received 09 Aug 2016, Accepted 21 Oct 2016, Published online: 22 Nov 2016

References

  • Waters TP, Mercer B. Preterm PROM: prediction, prevention, principles. Clin Obstet Gynecol 2011;54:307–12.
  • Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178–93.
  • Dutta EH, Behnia F, Boldogh I, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod 2016;22:143–57.
  • Murtha AP, Menon R. Regulation of fetal membrane inflammation: a critical step in reducing adverse pregnancy outcome. Am J Obstet Gynecol 2015;213:447–8.
  • Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010;203:361 e361–e330.
  • Lannon SM, Vanderhoeven JP, Eschenbach DA, et al. Synergy and interactions among biological pathways leading to preterm premature rupture of membranes. Reprod Sci 2014;21:1215–27.
  • Romero R, Miranda J, Chaemsaithong P, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2015;28:1394–409.
  • Cobo T, Palacio M, Martinez-Terron M, et al. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obstet Gynecol 2011;205:126 e121–8.
  • Musilova I, Kutova R, Pliskova L, et al. Intraamniotic inflammation in women with preterm prelabor rupture of membranes. PLoS One 2015;10:e0133929.
  • Le Ray I, Mace G, Sediki M, et al. Changes in maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study. Am J Reprod Immunol 2015;73:79–90.
  • Dorfeuille N, Morin V, Tetu A, et al. Vaginal fluid inflammatory biomarkers and the risk of adverse neonatal outcomes in women with PPROM. Am J Perinatol 2016;33:1003–7.
  • Buhimschi CS, Sfakianaki AK, Hamar BG, et al. A low vaginal “pool” amniotic fluid glucose measurement is a predictive but not a sensitive marker for infection in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2006;194:309–16.
  • Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839–51.
  • Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805–16.
  • Romero R, Jimenez C, Lohda AK, et al. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990;163:968–74.
  • Tambor V, Kacerovsky M, Andrys C, et al. Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis. PLoS One 2012;7:e41164.
  • Fritz IB, Burdzy K, Setchell B, Blaschuk O. Ram rete testis fluid contains a protein (clusterin) which influences cell–cell interactions in vitro. Biol Reprod 1983;28:1173–88.
  • Choi NH, Mazda T, Tomita M. A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes. Mol Immunol 1989;26:835–40.
  • Choi NH, Nakano Y, Tobe T, et al. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement. Int Immunol 1990;2:413–17.
  • Falgarone G, Chiocchia G. Chapter 8: Clusterin: a multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res 2009;104:139–70.
  • Grima J, Zwain I, Lockshin RA, et al. Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology 1990;126:2989–97.
  • Jordan-Starck TC, Lund SD, Witte DP, et al. Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. J Lipid Res 1994;35:194–210.
  • Oztas E, Ozler S, Ersoy AO, et al. Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia. J Perinat Med 2016;44:269–75.
  • Kolla V, Jeno P, Moes S, et al. Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol 2012;2012:305964.
  • Blumenstein M, McCowan LM, Wu S, et al. Plasma clusterin increased prior to small for gestational age (SGA) associated with preeclampsia and decreased prior to SGA in normotensive pregnancies. Reprod Sci 2012;19:650–7.
  • Shin JK, Han KA, Kang MY, et al. Expression of clusterin in normal and preeclamptic placentas. J Obstet Gynaecol Res 2008;34:473–9.
  • Watanabe H, Hamada H, Yamada N, et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics 2004;4:537–43.
  • Musilova I, Andrys C, Drahosova M, et al. Amniotic fluid calreticulin in pregnancies complicated by the preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2016;29:3921–9.
  • Musilova I, Andrys C, Drahosova M, et al. Amniotic fluid cathepsin-G in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2016. [Epub ahead of print]. doi: 10.1080/14767058.2016.1237499.
  • Kacerovsky M, Musilova I, Hornychova H, et al. Bedside assessment of amniotic fluid interleukin-6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol 2014;211:385.e1–9.
  • Fouhy F, Deane J, Rea MC, et al. The effects of freezing on faecal microbiota as determined using MiSeq sequencing and culture-based investigations. PLoS One 2015;10:e0119355.
  • Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 1994;32:335–51.
  • Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes. J Matern Fetal Neonatal Med 2016;29:349–59.
  • Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection. J Matern Fetal Neonatal Med 2016;29:360–7.
  • Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002;34:427–31.
  • Aronow BJ, Lund SD, Brown TL, et al. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA. 1993;90:725–9.
  • Hallstrom T, Uhde M, Singh B, et al. Pseudomonas aeruginosa uses dihydrolipoamide dehydrogenase (Lpd) to bind to the human terminal pathway regulators vitronectin and clusterin to inhibit terminal pathway complement attack. PLoS One 2015;10:e0137630.
  • Walport MJ. Complement. First of two parts. N Engl J Med 2001;344:1058–66.
  • Kirszbaum L, Sharpe JA, Murphy B, et al. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J 1989;8:711–18.
  • Jenne DE, Lowin B, Peitsch MC, et al. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A–I in human plasma. J Biol Chem 1991;266:11030–6.
  • Singh B, Su YC, Riesbeck K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol 2010;78:545–60.
  • Zipfel PF, Wurzner R, Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 2007;44:3850–7.
  • Zipfel PF, Hallstrom T, Riesbeck K. Human complement control and complement evasion by pathogenic microbes-tipping the balance. Mol Immunol 2013;56:152–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.